TipRanks
Regenerative Medical Technology Group (RMTG)
OTHER OTC:RMTG
US Market
RMTG
Regenerative Medical Technology Group
RESEARCH TOOLSreports
Want to see RMTG full AI Analyst Report?

Regenerative Medical Technology Group (RMTG) Income Statement

6 Followers

Regenerative Medical Technology Group Income Statement

Last quarter (Q2 2026), Regenerative Medical Technology Group's total revenue was $4.02M, an increase of 309.02% from the same quarter last year. In Q2, Regenerative Medical Technology Group's net income was $-2.91M. See Regenerative Medical Technology Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.10M$ 4.11M$ 2.41M$ 1.53M$ 437.89K
Gross Profit
$ 2.81M$ 2.82M$ 1.68M$ 876.97K$ 150.14K
Operating Expenses
$ 3.68M$ 2.38M$ 2.39M$ 2.06M$ 10.08M
Depreciation and Amortization
$ 281.07K$ 220.56K$ 310.10K$ 152.74K$ 40.86K
EBITDA
$ -83.56K$ 301.74K$ -3.01M$ -1.02M$ -10.11M
Operating Income
$ -867.16K$ 81.18K$ -715.23K$ -1.18M$ -9.93M
Other Income/Expenses
$ -6.95M$ -5.64M$ -9.10M$ -4.39M$ -2.95M
Pretax Income
$ -7.81M$ -5.56M$ -9.81M$ -5.58M$ -12.88M
Net Income
$ -7.81M$ -5.56M$ -9.81M$ -5.49M$ -12.88M
Per Share Metrics
Basic EPS
$ -0.62$ -0.44$ -0.79$ -0.45$ -1.12
Diluted EPS
$ -0.62$ -0.44$ -0.79$ -0.45$ -1.12
Weighted Average Shares Outstanding
 12.63M 12.53M 12.45M 12.22M 11.48M
Weighted Average Shares Outstanding (Diluted)
 12.63M 12.53M 12.45M 12.22M 11.48M
Currency in USD

Regenerative Medical Technology Group Earnings and Revenue History